{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:53:38Z","timestamp":1791550418867,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T00:00:00Z","timestamp":1635465600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"crossref","award":["University of Birmingham (UK)"],"award-info":[{"award-number":["University of Birmingham (UK)"]}],"id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001835","name":"Maastricht University","doi-asserted-by":"crossref","award":["Maastricht University (NL)"],"award-info":[{"award-number":["Maastricht University (NL)"]}],"id":[{"id":"10.13039\/501100001835","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sexually transmitted infections (STIs) and HIV can generate costs both within and outside the health sector (i.e. intersectoral costs). This systematic review aims (i) to explore the intersectoral costs associated with STIs and HIV considered in cost-of-illness (COI) studies, (ii) to categorise and analyse these costs according to cost sectors, and (iii) to illustrate the impact of intersectoral costs on the total cost burden.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Medline (PubMed), EMBASE (Ovid), Web of Science, CINAHL, PsycINFO, EconLit and NHS EED were searched between 2009 and 2019. Key search terms included terms for cost-of-illness, cost analysis and all terms for STIs including specific infections. Studies were included that assessed intersectoral costs. A standardised data extraction form was adopted. A cost component table was established based on pre-defined sector-specific classification schemes. Cost results for intersectoral costs were recorded. The quality of studies was assessed using a modified version of the CHEC-list.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>75 COI studies were considered for title\/abstract screening. Only six studies were available in full-text and eligible for data extraction and narrative synthesis. Intersectoral costs were captured in the following sectors: <jats:italic>Patient &amp; family, Informal care<\/jats:italic> and <jats:italic>Productivity (Paid Labour).<\/jats:italic> Patient &amp; family costs were addressed in four studies, including patient out-of-pocket payments\/co-payments and travel costs. Informal care costs including unpaid (home) care support by family\/friends and other caregiver costs were considered in three studies. All six studies estimated productivity costs for paid labour including costs in terms of absenteeism, disability, cease-to-work, presenteeism and premature death. Intersectoral costs largely contributed to the total economic cost burden of STIs and HIV. The quality assessment revealed methodological differences.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>It is evident that intersectoral costs associated with STIs and HIV are substantial. If relevant intersectoral costs are not included in cost analyses the total cost burden of STIs and HIV to society is severely underestimated. Therefore, intersectoral costs need to be addressed in order to ensure the total economic burden of STIs and HIV on society is assessed, and communicated to policy\/decision-makers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-021-07147-z","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T17:03:32Z","timestamp":1635527012000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Intersectoral costs of sexually transmitted infections (STIs) and HIV: a systematic review of cost-of-illness (COI) studies"],"prefix":"10.1186","volume":"21","author":[{"given":"Lena","family":"Schnitzler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggie T. G.","family":"Paulus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy E.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia M. A. A.","family":"Evers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"7147_CR1","unstructured":"World Health Organization. Sexually transmitted infections (STIs) 2019. Available from:https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/sexually-transmitted-infections-(stis)."},{"issue":"1","key":"7147_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1363\/3601104","volume":"36","author":"HW Chesson","year":"2004","unstructured":"Chesson HW, Blandford JM, Gift TL, Tao G, Irwin KL. The estimated direct medical cost of sexually transmitted diseases among American youth 2000. Perspect Sex Reprod Health. 2004;36(1):11\u20139.","journal-title":"Perspect Sex Reprod Health"},{"issue":"3","key":"7147_CR3","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/OLQ.0b013e318285c6d2","volume":"40","author":"K Owusu-Edusei Jr","year":"2013","unstructured":"Owusu-Edusei K Jr, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MCB, et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40(3):197\u2013201.","journal-title":"Sex Transm Dis"},{"key":"7147_CR4","unstructured":"Eng TR, Butler WT. Estimates of the economic burden of STDs: Review of the literature with updates. The hidden epidemic: Confronting sexually transmitted diseases. National Academies Press (US); 1997."},{"issue":"5","key":"7147_CR5","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1071\/SH13021","volume":"10","author":"K Owusu-Edusei","year":"2013","unstructured":"Owusu-Edusei K, Roby TM, Chesson HW, Gift TL. Productivity costs of nonviral sexually transmissible infections among patients who miss work to seek medical care: evidence from claims data. Sex Health. 2013;10(5):434\u20137.","journal-title":"Sex Health"},{"key":"7147_CR6","doi-asserted-by":"crossref","unstructured":"Kuhlmann J, Keaei M, Conde R, Evers SM, Gonzalez J, Govers M, et al. A cost-of-illness study of patients with HIV\/AIDS in Bogot\u00e1, Colombia. Value in health regional issues. 2017;14:103\u20137.","DOI":"10.1016\/j.vhri.2017.09.002"},{"issue":"4","key":"7147_CR7","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jval.2016.11.009","volume":"20","author":"M Remme","year":"2017","unstructured":"Remme M, Martinez-Alvarez M, Vassall A. Cost-effectiveness thresholds in global health: taking a multisectoral perspective. Value Health. 2017;20(4):699\u2013704.","journal-title":"Value Health"},{"issue":"4","key":"7147_CR8","first-page":"179","volume":"16","author":"R Drost","year":"2013","unstructured":"Drost R, Paulus A, Ruwaard D, Evers S. Inter-sectoral costs and benefits of mental health prevention: towards a new classification scheme. J Ment Health Policy Econ. 2013;16(4):179\u201386.","journal-title":"J Ment Health Policy Econ"},{"issue":"1","key":"7147_CR9","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.healthpol.2005.07.016","volume":"77","author":"R Tarricone","year":"2006","unstructured":"Tarricone R. Cost-of-illness analysis: what room in health economics? Health Policy. 2006;77(1):51\u201363.","journal-title":"Health Policy"},{"issue":"3","key":"7147_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1136\/ip.6.3.177","volume":"6","author":"DP Rice","year":"2000","unstructured":"Rice DP. Cost of illness studies: what is good about them? Inj Prev. 2000;6(3):177\u20139.","journal-title":"Inj Prev"},{"key":"7147_CR11","first-page":"5","volume-title":"Epidemiology of primary bone tumors and economical aspects of bone metastases","author":"EI Hauben","year":"2015","unstructured":"Hauben EI, Hogendoorn PC. Epidemiology of primary bone tumors and economical aspects of bone metastases. Bone cancer: Elsevier; 2015. pp.\u00a05\u201310."},{"issue":"4","key":"7147_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.3350\/cmh.2014.20.4.327","volume":"20","author":"C Jo","year":"2014","unstructured":"Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clinical molecular hepatology. 2014;20(4):327.","journal-title":"Clinical molecular hepatology"},{"key":"7147_CR13","unstructured":"Zorginstituut Nederland. Richtlijn voor het uitvoeren van economische evaluaties in de gezondheidszorg, 2016. www zorginstituutnederland nl. 2018."},{"key":"7147_CR14","unstructured":"Public Health England. Economic evaluation: health economic studies. Public Health England; 2021."},{"key":"7147_CR15","volume-title":"Guide to the methods of technology appraisal 2013","author":"National Institute for Health and Care Excellence (NICE)","year":"2013","unstructured":"National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal 2013. United Kingdom: National Institute for Health and Care Excellence; 2013."},{"key":"7147_CR16","doi-asserted-by":"crossref","unstructured":"Ozili PK, Arun T. Spillover of COVID-19: impact on the Global Economy. Available at SSRN 3562570. 2020.","DOI":"10.2139\/ssrn.3562570"},{"key":"7147_CR17","doi-asserted-by":"crossref","unstructured":"Fernandes N. Economic effects of coronavirus outbreak (COVID-19) on the world economy. Available at SSRN 3557504. 2020.","DOI":"10.2139\/ssrn.3557504"},{"key":"7147_CR18","doi-asserted-by":"crossref","unstructured":"Drost RM, Paulus AT, Jander AF, Mercken L, de Vries H, Ruwaard D, et al. A web-based computer-tailored alcohol prevention program for adolescents: cost-effectiveness and intersectoral costs and benefits. J Med Internet Res. 2016;18(4).","DOI":"10.2196\/jmir.5223"},{"key":"7147_CR19","unstructured":"Public Health England. Sexually transmitted infections and screening for chlamydia in England, 2017. Health Protection Report. 2018;12(20)."},{"issue":"4","key":"7147_CR20","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","volume":"151","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151(4):264\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"7147_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3163\/1536-5050.104.3.014","volume":"104","author":"WM Bramer","year":"2016","unstructured":"Bramer WM, Giustini D, de Jonge GB, Holland L, Bekhuis T. De-duplication of database search results for systematic reviews in EndNote. Journal of the Medical Library Association: JMLA. 2016;104(3):240.","journal-title":"Journal of the Medical Library Association: JMLA"},{"issue":"1","key":"7147_CR22","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1111\/j.1471-0528.2002.00223.x","volume":"109","author":"T Roberts","year":"2002","unstructured":"Roberts T, Henderson J, Mugford M, Bricker L, Neilson J, Garcia J. Antenatal ultrasound screening for fetal abnormalities: a systematic review of studies of cost and cost effectiveness. BJOG. 2002;109(1):44\u201356.","journal-title":"BJOG"},{"issue":"6","key":"7147_CR23","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1080\/14737167.2016.1246961","volume":"16","author":"B Wijnen","year":"2016","unstructured":"Wijnen B, Van Mastrigt G, Redekop W, Majoie H, De Kinderen R, Evers S. How to prepare a systematic review of economic evaluations for informing evidence-based healthcare decisions: data extraction, risk of bias, and transferability (part 3\/3). Expert Rev Pharmacoecon Outcomes Res. 2016;16(6):723\u201332.","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"7147_CR24","unstructured":"Drummond MF, Sculpher MJ, Claxton K, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford university press; 2015."},{"key":"7147_CR25","unstructured":"Inflation Tool. Available from: https:\/\/www.inflationtool.com\/. Accessed 25 Aug 2021."},{"key":"7147_CR26","unstructured":"Currency Converter. Available from: https:\/\/www.xe.com\/. Accessed 25 Aug 2021."},{"issue":"2","key":"7147_CR27","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1017\/S0266462305050324","volume":"21","author":"S Evers","year":"2005","unstructured":"Evers S, Goossens M, De Vet H, Van Tulder M, Ament A. Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic Criteria. Int J Technol Assess Health Care. 2005;21(2):240\u20135.","journal-title":"Int J Technol Assess Health Care"},{"issue":"8","key":"7147_CR28","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2165\/11588380-000000000-00000","volume":"29","author":"A Larg","year":"2011","unstructured":"Larg A, Moss JR. Cost-of-Illness Studies. Pharmacoeconomics. 2011;29(8):653\u201371.","journal-title":"Pharmacoeconomics"},{"key":"7147_CR29","volume-title":"Assessing the challenges of applying standard methods of economic evaluation to public health interventions","author":"M Drummond","year":"2007","unstructured":"Drummond M, Weatherly H, Claxton K, Cookson R, Ferguson B, Godfrey C, et al. Assessing the challenges of applying standard methods of economic evaluation to public health interventions. York: Public Health Research Consortium; 2007."},{"issue":"2-3","key":"7147_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.healthpol.2009.07.012","volume":"93","author":"H Weatherly","year":"2009","unstructured":"Weatherly H, Drummond M, Claxton K, Cookson R, Ferguson B, Godfrey C, et al. Methods for assessing the cost-effectiveness of public health interventions: key challenges and recommendations. Health Policy. 2009;93(2-3):85\u201392.","journal-title":"Health Policy"},{"issue":"3","key":"7147_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1007\/s10620-009-0786-4","volume":"55","author":"B-M Yang","year":"2010","unstructured":"Yang B-M, Kim DJ, Byun KS, Kim HS, Park J-W, Shin S. The societal burden of HBV-related disease: South Korea. Dig Dis Sci. 2010;55(3):784\u201393.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"7147_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1472-6963-9-55","volume":"9","author":"J Lopez-Bastida","year":"2009","unstructured":"Lopez-Bastida J, Oliva-Moreno J, Perestelo-Perez L, Serrano-Aguilar P. The economic costs and health-related quality of life of people with HIV\/AIDS in the Canary Islands, Spain. BMC Health Serv Res. 2009;9(1):55.","journal-title":"BMC Health Serv Res"},{"key":"7147_CR33","unstructured":"Shon C, Choi H-Y, Shim J-J, Park S-Y, Lee KS, Yoon S-J, et al. The economic burden of hepatitis A, B, and C in South Korea. Jpn J Infect Dis. 2015:JJID. 2014.499."},{"issue":"6","key":"7147_CR34","first-page":"e133-42","volume":"77","author":"A Kuhlmann","year":"2015","unstructured":"Kuhlmann A, Mittendorf T, Hower M, Heiken H, Gerschmann S, Klauke S, et al. Cost of illness of HIV patients under anteretroviral therapy in Germany-Results of the 48-week interim analysis of the prospective multicentre observational study\u2019CORSAR\u2019. Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany)). 2015;77(6):e133-42.","journal-title":"Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))"},{"issue":"5","key":"7147_CR35","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s10198-012-0425-4","volume":"14","author":"S Mostardt","year":"2013","unstructured":"Mostardt S, Hanhoff N, Wasem J, Goetzenich A, Schewe K, Wolf E, et al. Cost of HIV and determinants of health care costs in HIV-positive patients in Germany: results of the DAGN\u00c4 K3A Study. Eur J Health Econ. 2013;14(5):799\u2013808.","journal-title":"Eur J Health Econ"},{"key":"7147_CR36","doi-asserted-by":"crossref","unstructured":"Schnitzler L, Janssen LM, Evers SM, Jackson LJ, Paulus AT, Roberts TE, et al. The broader societal impacts of COVID-19 and the growing importance of capturing these in health economic analyses. Int J Technol Assess Health Care. 2021;37.","DOI":"10.1017\/S0266462321000155"},{"issue":"2","key":"7147_CR37","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1017\/S0266462317000526","volume":"33","author":"RM Drost","year":"2017","unstructured":"Drost RM, van der Putten IM, Ruwaard D, Evers SM, Paulus AT. Conceptualizations of the societal perspective within economic evaluations: a systematic review. Int J Technol Assess Health Care. 2017;33(2):251\u201360.","journal-title":"Int J Technol Assess Health Care"},{"key":"7147_CR38","volume-title":"Estimating the cost-of-illness","author":"DP Rice","year":"1966","unstructured":"Rice DP. Estimating the cost-of-illness. Washington, DC: US Department of Health, Education, and Welfare. Public Health Service; 1966."},{"issue":"4","key":"7147_CR39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s10198-015-0685-x","volume":"17","author":"M Krol","year":"2016","unstructured":"Krol M, Papenburg J, Tan SS, Brouwer W, Hakkaart L. A noticeable difference? Productivity costs related to paid and unpaid work in economic evaluations on expensive drugs. Eur J Health Econ. 2016;17(4):391\u2013402.","journal-title":"Eur J Health Econ"},{"issue":"6","key":"7147_CR40","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s40258-018-0416-4","volume":"16","author":"J Pike","year":"2018","unstructured":"Pike J, Grosse SD. Friction cost estimates of productivity costs in cost-of-illness studies in comparison with human capital estimates: a review. Appl Health Econ Health Policy. 2018;16(6):765\u201378.","journal-title":"Appl Health Econ Health Policy"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-07147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-021-07147-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-021-07147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,30]],"date-time":"2021-10-30T04:04:12Z","timestamp":1635566652000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-021-07147-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["7147"],"URL":"https:\/\/doi.org\/10.1186\/s12913-021-07147-z","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,29]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1179"}}